Development of an optimal S9 activation
Development of an optimal S9 activation mixture for the L5178Y TK+/โ mouse lymphoma mutation assay
โ
Jenness B. Majeska; Dale W. Matheson; H. E. Holden
๐
Article
๐
1990
๐
John Wiley and Sons
๐
English
โ 667 KB
In previously described activation systems [Clive D, Spector : Mutat Res 31:17-291 for the mouse lymphoma mutation assay the cofactor isocitrate is rapidly exhausted and the resultant loss of NADPH can halt metabolic processes. Presented here are data obtained with a nontoxic b'olance of NADP (1.4 m